Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection -: art. no. 93

被引:95
作者
Ostergaard, C
Konradsen, HB
Samuelsson, S
机构
[1] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, Copenhagen S, Denmark
[2] Statens Serum Inst, Dept Bacteriol Mycol & Parasitol, Copenhagen S, Denmark
[3] Statens Serum Inst, Dept Epidemiol, Copenhagen S, Denmark
关键词
D O I
10.1186/1471-2334-5-93
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: We conducted a nationwide study in Denmark to identify clinical features and prognostic factors in patients with Streptococcus pneumoniae according to the focus of infection. Methods: Based on a nationwide registration, clinical information's was prospectively collected from all reported cases of pneumococcal meningitis during a 2-year period ( 1999 - 2000). Clinical and laboratory findings at admission, clinical course and outcome of the disease including follow-up audiological examinations were collected retrospectively. The focus of infection was determined according to the clinical diagnosis made by the physicians and after review of the medical records. Results: 187 consecutive cases with S. pneumoniae meningitis were included in the study. The most common focus was ear (30%), followed by lung (18%), sinus (8%), and other (2%). In 42% of cases a primary infection focus could not be determined. On admission, fever and an altered mental status were the most frequent findings ( in 93% and 94% of cases, respectively), whereas back rigidity, headache and convulsion were found in 57%, 41% and 11% of cases, respectively. 21% of patients died during hospitalisation ( adults: 27% vs. children: 2%, Fisher Exact Test, P < 0.001), and the causes of death were due to neurological - and systemic complications or the combination of both in 8%, 5% and 6% of cases, respectively. Other causes ( e. g. gastrointestinal bleeding, incurable cancer) accounted for 2% of cases. 41% of survivors had neurological sequelae ( hearing loss: 24%, focal neurological deficits: 16%, and the combination of both: 1%). The mortality varied with the focus of the infection ( otogenic: 7%, sinusitic: 33%, pneumonic: 26%, other kind of focus: 50%, no primary infection focus: 21%, Log rank test: P = 0.0005). Prognostic factors associated with fatal outcome in univariate logistic regression analysis were advanced age, presence of an underlying disease, history of headache, presence of a lung focus, absence of an otogenic focus, having a CT-scan prior to lumbar puncture, convulsions, requirement of assisted ventilation, and alterations in various CSF parameters (WBC < 500 cells/mu L, high protein levels, glucose levels< 1 mmol/L, low CSF/blood glucose levels), P < 0.05. Independent prognostic factor associated with fatal outcome in multivariate logistic regression analysis was convulsions ( OR: 4.53, 95% CI: (1.74 - 11.8), p = 0.002), whereas presence of an otogenic focus was independently associated with a better survival ( OR: 6.09, 95% CI: ( 1.75 - 21.2), P = 0.005). Conclusion: These results emphasize the prognostic importance of an early recognition of a predisposing focus to pneumococcal meningitis.
引用
收藏
页数:11
相关论文
共 31 条
[1]   Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing [J].
Aronin, SI ;
Peduzzi, P ;
Quagliarello, VJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :862-869
[2]   Pneumococcal meningitis in the intensive care unit -: Prognostic factors of clinical outcome in a series of 80 cases [J].
Auburtin, M ;
Porcher, R ;
Bruneel, F ;
Scanvic, A ;
Trouillet, JL ;
Bédos, JP ;
Régnier, B ;
Wolff, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (05) :713-717
[3]   PNEUMOCOCCAL MENINGITIS - AN EVALUATION OF PROGNOSTIC FACTORS IN 164 CASES BASED ON MORTALITY AND ON A STUDY OF LASTING SEQUELAE [J].
BOHR, V ;
RASMUSSEN, N ;
HANSEN, B ;
GADE, A ;
KJERSEM, H ;
JOHNSEN, N ;
PAULSON, O .
JOURNAL OF INFECTION, 1985, 10 (02) :143-157
[4]   CLINICAL-EVALUATION OF PNEUMOCOCCAL MENINGITIS IN ADULTS OVER A 12-YEAR PERIOD [J].
BRUYN, GAW ;
KREMER, HPH ;
DEMARIE, S ;
PADBERG, GW ;
HERMANS, J ;
VANFURTH, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (08) :695-700
[5]   Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146
[6]   Dexamethasone in adults with bacterial meningitis. [J].
de Gans, J ;
van de Beek, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1549-1556
[7]   Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance [J].
Fiore, AE ;
Moroney, JF ;
Farley, MM ;
Harrison, LH ;
Patterson, JE ;
Jorgensen, JH ;
Cetron, M ;
Kolczak, MS ;
Breiman, RF ;
Schuchat, A .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :71-77
[8]  
Hoen B, 1993, Eur J Med, V2, P28
[9]   Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation [J].
Ispahani, P ;
Slack, RCB ;
Donald, FE ;
Weston, VC ;
Rutter, N .
ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (08) :757-762
[10]   Effectiveness of pneumococcal polysaccharide vaccine in older adults [J].
Jackson, LA ;
Neuzil, KM ;
Yu, OC ;
Benson, P ;
Barlow, WE ;
Adams, AL ;
Hanson, CA ;
Mahoney, LD ;
Shay, DK ;
Thompson, WW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1747-1755